Clinical Trials Browser

Withdrawn × Neoplastic Cells, Circulating × Cetuximab × Clear all

NCT04648189 2023-10-19

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Phase 2 Withdrawn

Lung Neoplasms, Neoplastic Cells, Circulating